Kirsty, Biocon's rapid-acting insulin, is the first FDA-approved interchangeable biosimilar to NovoLog in the US and will be ...

Biocon Biologics receives USFDA approval for Kirsty, an interchangeable biosimilar to NovoLog, expanding their insulin ...

The US diabetes market presents a substantial opportunity for Biocon Biologics, with 38.4 million people living with diabetes ...

Kirsty is biosimiler to Novolog. It is a rapid-acting human insulin analog indicated to improve glycemic control in adults ...

Insulin Aspart is a rapid-acting type of insulin sold as generic Insulin Aspart and under the brand name Novolog, the ADCES says. Another version of Insulin Aspart, Fiasp, ...

Insulin Aspart is a rapid-acting type of insulin sold as generic Insulin Aspart and under the brand name Novolog, the ADCES says. Another version of Insulin Aspart, Fiasp, ...

Insulin Aspart is a rapid-acting type of insulin sold as generic Insulin Aspart and under the brand name Novolog, the ADCES says. Another version of Insulin Aspart, Fiasp, ...

Three insulin products are currently in shortage, ... Novo Nordisk is discontinuing Levemir and has a shortage of some Insulin Aspart and Novolog products. Other insulin injections are not in ...

Insulin Aspart is a rapid-acting type of insulin sold as generic Insulin Aspart and under the brand name Novolog, the ADCES says. Another version of Insulin Aspart, Fiasp, ...

Insulin Aspart is a rapid-acting type of insulin sold as generic Insulin Aspart and under the brand name Novolog, the ADCES says. Another version of Insulin Aspart, Fiasp, ...

Three insulin products are currently in shortage, but all other insulin products are in good supply, including alternatives for the limited products.